Genetek Lifesciences to offer Amphotericin B injection for COVID triggered black fungus for Rs 1200

Published On 2021-05-15 05:00 GMT   |   Update On 2021-05-15 13:07 GMT

Nagpur: On the initiative of Union Minister Nitin Gadkari, Genetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister's office said.Its production will begin in the next 15 days at its Wardha plant.Right now the cost of an injection is Rs 7,000 and people are not getting...

Login or Register to read the full article

Nagpur: On the initiative of Union Minister Nitin Gadkari, Genetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister's office said.

Its production will begin in the next 15 days at its Wardha plant.

Right now the cost of an injection is Rs 7,000 and people are not getting it easily.

The injection made in Wardha will be available for just Rs 1,200, it added.

A total of 20,000 injections per day will be manufactured in the plant.

Read also: NPPA to monitor supply arrangements for Mucormycosis drug Amphotericin B

Genetek Lifesciences started production of Remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday.

The company has received a loan licence to manufacture Remdesivir.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News